Plasma C-peptide and cognitive performance in older men without diabetes

American Journal of Geriatric Psychiatry

Volumn 14, Issue 12, 2006, Pages 1041-1050

  Okereke, Olivia ^a,d   Kang, Jae H ^a   Gaziano, J Michael ^a,c   Ma, Jing ^a   Stampfer, Meir J ^a,b   Grodstein, Francine ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

Aging; C peptide; Cognition; Diabetes; Insulin

Indexed keywords

C PEPTIDE; INSULIN;

ADULT; AGED; AGING; ARTICLE; BLOOD SAMPLING; COGNITION; COHORT ANALYSIS; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RATING SCALE; REGRESSION ANALYSIS; SCORING SYSTEM; TELEPHONE; TELEPHONE INTERVIEW OF COGNITIVE STATUS; UNITED STATES; VERBAL MEMORY;

EID: 33845592513     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.JGP.0000240983.25359.00     Document Type: Article

References (44)

1. Coker LH, Shumaker SA: Type 2 diabetes mellitus and cognition: an understudied issue in women's health. J Psychosom Res 2003; 54:129-139
2. Biessels GJ, Staekenborg S, Brunner E, et al: Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5:64-74
3. Ott A, Stolk RP, van Harskamp F, et al: Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 1999;53:1937-1942
4. Stolk RP, Breteler MMB, Ott A, et al: Insulin and cognitive function in an elderly population: the Rotterdam study. Diabetes Care 1997;20:792-795
5. Watson GS, Peskind ER, Asthana S, et al: Insulin increases CSF Abeta42 levels in normal older adults. Neurology 2003;60:1899-1903
6. Farris W, Mansourian S, Chang Y, et al: Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 2003; 100:4162-4167
7. Gasparini L, Gouras GK, Wang R, et al: Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 2001; 21:2561-2570
8. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353-356
9. Hovorka R, Jones RH: How to measure insulin secretion. Diabetes Metab Res Rev 1994; 10:91-117
10. The Steering Committee of the Physicians' Health Study Research Group: Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321:129-135.
11. The Steering Committee of the Physicians' Health Study Research Group: Preliminary report: findings from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1988; 318:262-264.
12. Christen WG, Gaziano JM, Hennekens CH, for the Steering Committee of the Physicians' Health Study, II:Design of Physicians' Health Study II: a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000; 10:125-134
13. Hak AE, Ma J, Powell CB, et al: Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke 2004; 35:1584-1588
14. Chan JM, Stampfer MJ, Ma J, et al: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 2002; 94:1099-1106
15. Ma J, Giovannucci E, Pollak M, et al: A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004; 96:546-553
16. Faber OK, Binder C, Markussen J, et al: Characterization of seven C-peptide antisera. Diabetes 1978; 27(suppl 1):170-177
17. Steiner DF, Rubenstein AH: Proinsulin C-peptide-biological activity? Science 1997; 277:531-532
18. Wahren J, Ekberg K, Johansson J, et al: Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 2000; 278: E759-768
19. Polonsky KS, Rubenstein AH: C-peptide as a measure of the secretion and hepatic extraction of insulin: pitfalls and limitations. Diabetes 1984; 33:486-494
20. Berger B, Stenstrom G, Sundkvist G: Random C-peptide in the classification of diabetes. Scand J Clin Lab Invest 2000; 60:687-694
21. Brandt J, Spencer M, Folstein M: The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol. 1988; 1:111-117
22. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
23. Albert M, Smith IA, Scherr PA, et al: Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991; 57:167-178
24. Lotufo PA, Gaziano JM, Chae CU, et al: Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 2001; 161:248-251
25. Manson JE, Grobbee DE, Stampfer MJ, et al: Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med 1990; 89:772-776
26. Chen P, Ratcliff G, Belle SH, et al: Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001; 58:853-858
27. Small BJ, Fratiglioni L, Viitanen M, et al: The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 2000; 57:839-844
28. Elias MF, Beiser A, Wolf PA, et al: The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol 2000; 57:808-813
29. Wilson RS, Schneider JA, Barnes LL, et al: The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 2002; 59:1154-1160
30. Vermeer SE, Prins ND, den Heijer T, et al: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348:1215-1222
31. Geroldi C, Frisoni GB, Paolisso G, et al: Insulin resistance in cognitive impairment: the InCHIANTI study. Arch Neurol 2005; 62:1067-1072
32. Zhao WQ, Alkon DL: Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 2001; 177:125-134
33. Palovcik RA, Phillips MI, Kappy MS, et al: Insulin inhibits pyramidal neurons in hippocampal slices. Brain Res 1984; 309:187-191
34. Brass BJ, Nonner D, Barrett JN: Differential effects of insulin on choline acetyltransferase and glutamic acid decarboxylase activities in neuron-rich striatal cultures. J Neurochem 1992; 59:415-424
35. Gold PE: Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem 2003; 80:194-210
36. Mohapel P, Leanza G, Kokaia M, et al: Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning. Neuro biol Aging 2005; 26:939-946
37. Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: progress and potential. Endocr Rev 1998; 19:608-624
38. Kurochkin IV, Goto S: Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 1994; 345:33-37
39. McDermott JR, Gibson AM: Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem Res 1997; 22:49-56
40. Kuusisto J, Koivisto K, Mykkanen L, et al: Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 1997; 315:1045-1049
41. Kalmijn S, Feskens EJM, Launer LJ, et al: Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995; 38:1096-1102
42. Okereke O, Hankinson SE, Hu FB, et al: Plasma c-peptide and cognitive function among older women without diabetes. Arch Intern Med 2005; 165:1651-1656
43. Luchsinger J, Tang M-X, Shea S, et al: Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63:1187-1192
44. Yaffe K, Blackwell T, Kanaya AM, et al: Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63:658-663